RET-IN-28
Product Specifications
UNSPSC Description
RET-IN-28 (Compound 16) is a RET (transmembrane receptor tyrosine protein kinase) inhibitor. RET-IN-28 inhibits the activity of the mutant RET enzyme (RET-V804M), and can be applied to cancer research[1].
Target Antigen
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ret-in-28.html
Smiles
CC(C=C1)=NC=C1CN(C(C2)C3)C2CN3C4=NC=C(C5=NC(NC6=NNC(C)=C6)=CC(C)=N5)C=C4
Molecular Weight
467.57
References & Citations
[1]Chen Z, et al. Heterocyclic compound, pharmaceutical composition comprising same, preparation method therefor, and use thereof. World Intellectual Property Organization, WO2020168939A1. 2020-08-27.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-170019/RET-IN-28-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-170019/
Clinical Information
No Development Reported
CAS Number
2479961-45-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx213322-01 50 µL
Guanine Nucleotide Binding Protein (G Protein), gamma 2 (GNG2) Antibody
Ask
View Details abx213322-02 100 µL
Guanine Nucleotide Binding Protein (G Protein), gamma 2 (GNG2) Antibody
Ask
View Details